Safety and Efficacy Evaluation of S (+) - Ketamine in Children
NCT04834427 · Chinese PLA General Hospital
What it is testing
Summary
Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.
What counts as success
Primary outcome measures
The area under the broken line of FLACC scale score
Measured over Hour 0-48 after surgery
The area under the broken line of Numerical Rating Scale score
Measured over Hour 0-48 after surgery
Opioid consumption
Measured over Hour 0-48 after surgery
A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.
Who can take part
Eligibility, as published
Where
1 study site
| Facility | City | Region | Country |
|---|---|---|---|
| Chinese PLA General Hospital | Beijing | Beijing Municipality | China |
On the registry
Contact the trial directly
This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.
Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.
NCT04834427 on ClinicalTrials.gov →
Last updated in the registry 2024-03-08. Registry records change; this page reflects the data build of 2026-08-25.
Related